What is he best known for?
The fields of study he is best known for:
His main research concerns Nanotechnology, Drug delivery, Nanoparticle, Nanomedicine and Aptamer.
Omid C. Farokhzad interconnects Biocompatibility and Diagnostic modalities in the investigation of issues within Nanotechnology.
His Drug delivery research is multidisciplinary, relying on both Scale, Drug and Doxorubicin.
His studies deal with areas such as Biophysics, Ethylene glycol, Polymer and In vivo as well as Nanoparticle.
Omid C. Farokhzad has included themes like Cancer, Microfluidics, Engineering ethics, Enhanced permeability and retention effect and Pharmacology in his Nanomedicine study.
His Aptamer study integrates concerns from other disciplines, such as Cancer cell, LNCaP, Prostate cancer and Controlled release.
His most cited work include:
- Nanocarriers as an emerging platform for cancer therapy (5854 citations)
- Factors Affecting the Clearance and Biodistribution of Polymeric Nanoparticles (2312 citations)
- Impact of Nanotechnology on Drug Delivery (2054 citations)
What are the main themes of his work throughout his whole career to date?
His primary areas of study are Nanotechnology, Nanoparticle, Drug delivery, Cancer research and In vivo.
His Nanotechnology research focuses on subjects like Aptamer, which are linked to Cancer cell and LNCaP.
His Nanoparticle research focuses on Biophysics and how it relates to Biochemistry.
His Drug delivery research incorporates elements of Controlled release, Biodistribution and Drug.
His work deals with themes such as Cancer, Prostate cancer, Docetaxel, Antigen and RNA interference, which intersect with Cancer research.
He works mostly in the field of In vivo, limiting it down to concerns involving Pharmacology and, occasionally, Insulin.
He most often published in these fields:
- Nanotechnology (51.66%)
- Nanoparticle (39.81%)
- Drug delivery (31.52%)
What were the highlights of his more recent work (between 2017-2021)?
- Cancer research (24.41%)
- Nanotechnology (51.66%)
- Nanomedicine (18.72%)
In recent papers he was focusing on the following fields of study:
His primary areas of investigation include Cancer research, Nanotechnology, Nanomedicine, Nanoparticle and Drug delivery.
He has researched Cancer research in several fields, including Cancer, Apoptosis, Fibrous cap, Messenger RNA and Gene silencing.
His work in the fields of Photothermal therapy and Germanene overlaps with other areas such as Black phosphorus.
The study incorporates disciplines such as Nanomaterials and Nanostructure in addition to Nanomedicine.
His Nanoparticle research includes elements of Combinatorial chemistry and Coaxial.
As part of one scientific family, Omid C. Farokhzad deals mainly with the area of Drug delivery, narrowing it down to issues related to the Pharmacokinetics, and often Neovascularization, Biodistribution, Apolipoprotein B, Fibronectin and Pathology.
Between 2017 and 2021, his most popular works were:
- Emerging two-dimensional monoelemental materials (Xenes) for biomedical applications (218 citations)
- Two-Dimensional Antimonene-Based Photonic Nanomedicine for Cancer Theranostics. (197 citations)
- Intracellular Mechanistic Understanding of 2D MoS2 Nanosheets for Anti-Exocytosis-Enhanced Synergistic Cancer Therapy (93 citations)
In his most recent research, the most cited papers focused on:
Omid C. Farokhzad spends much of his time researching Nanotechnology, Cancer research, Apoptosis, Photothermal therapy and Nanomedicine.
His Nanotechnology research is multidisciplinary, incorporating perspectives in Brain disease and Disease therapy.
His Cancer research study incorporates themes from Cell, Prostate, Tensin, PI3K/AKT/mTOR pathway and In vivo.
His studies in Apoptosis integrate themes in fields like Cancer, HCCS, Cisplatin and Drug resistance.
His Nanomedicine study combines topics in areas such as Cancer cell, Exocytosis, Energy metabolism, Nanomaterials and Endosome.
In his research, Drug delivery is intimately related to Wound infection, which falls under the overarching field of Germanene.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
